Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ignacio Gil-Bazo

10PUBLICATIONS
72CO-AUTHORS
Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Aug 20, 2024
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|May 30, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|Mar 14, 2024
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|Feb 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<sub>reg</sub> cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|Oct 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.

Irati Macaya, Marta Roman, Connor Welch

|Mar 22, 2023
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in <i>NRAS</i>-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.

Filippo de Braud, Christophe Dooms, Rebecca S Heist

Pageof 2

Frequent Collaborators

4 joint publications

Delvys Rodriguez Abreu

4 joint publications

Namrata S Patil

4 joint publications

Ira Mellman

4 joint publications

Byoung Chul Cho

4 joint publications

Robert J Johnston

4 joint publications

Melissa Johnson

4 joint publications

David S Shames

4 joint publications

Antoine Italiano

4 joint publications

Patrick S Chang

4 joint publications

Barzin Y Nabet

Frequent Collaborators

4 joint publications

Delvys Rodriguez Abreu

4 joint publications

Namrata S Patil

4 joint publications

Ira Mellman

4 joint publications

Byoung Chul Cho

Top Related Videos

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.7K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.0K
See more related videos

Top Related Videos

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.7K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.0K
See more related videos